Post concussion syndrome (PCS) is a set of symptoms succeeding in 25 % of mild traumatic brain injury (mTBI) patients. Hyperbaric oxygen therapy (HBOT) has been demonstrated as an effective method for treating acute and severe TBI, but its efficacy in PCS remains controversial. In this editorial, we reviewed the clinical studies of HBOT in PCS, summarized the limitations of these studies, and discussed the limitations: inappropriate Sham group using room air at 1.2 or 1.3 ATA; delayed HBO administration; subjective assessment methods; time point for outcome assessment and small sample size. We hope that our concerns will be helpful for future clinical studies of HBO therapy in TBI or other neurological disorders.
Hu, Q., Manaenko, A., Guo, Z., Huang, L., Tang, J., & Zhang, J. H. (2015, August 25). Hyperbaric oxygen therapy for post concussion symptoms: Issues may affect the results. Medical Gas Research. BioMed Central Ltd. https://doi.org/10.1186/s13618-015-0033-3